ArticleiScience2024
Regorafenib promotes antitumor progression in melanoma by reducing RRM2.
Xiuyun Xuan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticleiScience2024
Xiuyun Xuan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.